Literature DB >> 34887604

Clozapine Induced Hypertension and its Association with Autonomic Dysfunction.

M B Deepak1, Kalra Deeksha1, Rajhans Pallavi1, Choudhary Hemant1, Bajaj Nidhisha1, Deep Raman1.   

Abstract

Clozapine is a second generation antipsychotic agent which is drug of choice for treatment resistant schizophrenia. Tachycardia and postural hypotension are most frequently observed cardiovascular adverse effects, but reports on new-onset persistently elevated blood pressure are sparse. Mechanisms underlying clozapine induced hypertension also remain unclear. We report the case of a 32 year old normotensive male with persistently elevated systolic and diastolic blood pressure after clozapine initiation. Hypertension persisted throughout the phase of dose optimization and dose stabilization at 300 mg/day, requiring an addition of a beta blocker (atenolol) after a month of observation. The 24 hour urinary catecholamines were within normal limits. Autonomic function tests revealed severe loss of parasympathetic activity and cardiac autonomic tone. The case adds to limited information on autonomic dysfunction as a potential factor in clozapine induced hypertension.
Copyright © 1964–2021 by MedWorks Media Inc, Los Angeles, CA All rights reserved. Printed in the United States.

Entities:  

Keywords:  adverse effects; clozapine; hypertension

Mesh:

Substances:

Year:  2021        PMID: 34887604      PMCID: PMC8601757     

Source DB:  PubMed          Journal:  Psychopharmacol Bull        ISSN: 0048-5764


  13 in total

1.  Pedal edema associated with clozapine use.

Authors:  R Durst; S Raskin; G Katz; J Zislin; R Durst
Journal:  Isr Med Assoc J       Date:  2000-06       Impact factor: 0.892

2.  Drug Points: Pseudophaeochromocytoma syndrome associated with clozapine.

Authors:  A J Krentz; S Mikhail; P Cantrell; G M Hill
Journal:  BMJ       Date:  2001-05-19

3.  Autonomic signs and dosing during the initial stages of clozapine therapy.

Authors:  L Kola Oyewumi; Zack Z Cernovsky; David J Freeman
Journal:  Med Sci Monit       Date:  2004-02

4.  Pseudophaeochromocytoma associated with clozapine therapy: a case report.

Authors:  O Akinsola; K Ong
Journal:  Afr J Psychiatry (Johannesbg)       Date:  2011-11

5.  Blood pressure changes during clozapine or olanzapine treatment in Korean schizophrenic patients.

Authors:  Young Sup Woo; Won Kim; Jeong-Ho Chae; Bo-Hyun Yoon; Won-Myong Bahk
Journal:  World J Biol Psychiatry       Date:  2009       Impact factor: 4.132

6.  Hypokalemic hypertension related to clozapine: a case report.

Authors:  Ewout J Hoorn; Marcel F P van der Poel
Journal:  J Clin Psychopharmacol       Date:  2014-06       Impact factor: 3.153

7.  Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine.

Authors:  J Kane; G Honigfeld; J Singer; H Meltzer
Journal:  Arch Gen Psychiatry       Date:  1988-09

8.  Blood Pressure and Heart Rate Changes During Clozapine Treatment.

Authors:  Sarah M Norman; Kelli M Sullivan; Fang Liu; Bethany A DiPaula; Pedro A Jose; Christopher A Kitchen; Stephanie M Feldman; Deanna L Kelly
Journal:  Psychiatr Q       Date:  2017-09

Review 9.  Unique Effects of Clozapine: A Pharmacological Perspective.

Authors:  Jibran Y Khokhar; Angela M Henricks; Emily D K Sullivan; Alan I Green
Journal:  Adv Pharmacol       Date:  2018-01-12

10.  Clozapine and hypertension: a chart review of 82 patients.

Authors:  David C Henderson; Tara B Daley; Laura Kunkel; Myisha Rodrigues-Scott; Pamposh Koul; Doug Hayden
Journal:  J Clin Psychiatry       Date:  2004-05       Impact factor: 4.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.